Business
Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages
Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages.
About this update from Medical Care Technologies Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages\r\n \r\n \r\n\r\n\r\nMedical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages\r\n\r\n\r\n\r\n\r\n\r\nCompany to Launch AI Food & Recipe App to Access Trillion-Dollar Global Food Market While Advancing Medical AI Pipeline MESA, ARIZONA / ACCESS Newswire / December 15, 2025 / Medical Care Technologies, Inc. (OTC Pink:MDCE) today announced the completion of its first AI-based consumer application, marking a major milestone in the Company's strategy to build scalable, revenue-generating artificial intelligence platforms while continuing development of advanced medical AI solutions. \r\n \r\n The newly completed application is designed for broad consumer adoption and global reach. The app is expected to be deployed in over 100 countries and made available in more than 30 languages, positioning it as a potential high-impact revenue driver for the Company.\r\n \"We decided to launch this application first because it offers the greatest consumer reach,\" said Marshall Perkins, CEO of Medical Care Technologies, Inc. \"This is an app that can be used by most people around the world. We believe consumer-facing AI applications like this can become significant revenue drivers over time, while also laying the groundwork for the future AI platforms we are developing.\"\r\n The initial launch focuses on a dietary and nutrition-based AI application, targeting a multi-billion-dollar global market. The app leverages artificial intelligence to deliver personalized dietary functionality to users in a unique fashion, supporting the Company's broader vision of building accessible, scalable AI solutions.\r\n Importantly, the Company emphasized that this consumer launch does not detract from its core medical initiatives.\r\n \"While we are launching a consumer dietary app first due to its market size and adoption potential, we are not losing focus on our medical determinations,\" Perkins added. \"We have also reached a significant milestone in the coding development of our first AI-driven melanoma detection application.\"\r\n The melanoma detection application is currently under development, with its name and of...